Background
Genitourinary infection with Chlamydia trachomatis is the commonest bacterial sexually transmitted disease in the UK.' In women it can have serious long term sequelae, such as pelvic inflammatory disease, chronic pelvic pain and infertility, which have significant personal, social and financial costs.6 Because up to 70% of infection in women may be asymptomatic, early detection of lower genital tract infection poses a challenge for clinicians. 7 Recently there has been much discussion about the possibility of screening women for asymptomatic infection,8 especially those thought to be at particular risk of complications: for example, those having a termination of pregnancy.9 However, most existing tests are poorly sensitive, that is, fail to identify all of those infected's"2 and require cervical or urethral samples to be collected.
The ligase chain reaction is a relatively new test that uses gene amplification techniques to Are the methods for performing the test described in enough detail to permit replication? In the study under review, the methods are described in detail, particularly the LCR testing, which is a novel test with few previous applications described in the literature.
In summary, this study meets the criteria for validity set out above. Once satisfied that the results in a given study are When we evaluate a patient by taking a history and performing a physical examination, the probability of them having a given disease can be estimated. This probability is called the "pre-test probability." While clinicians rarely make formal estimates of pre-test probability, they nevertheless subconsciously estimate how likely it is that patients have a given disease when taking a history and examining them.
There is also literature quantifying the accuracy of history and examination in determining pre-test probability. 21 The likelihood ratio (LR) is a numerical tool which allows clinicians to build on their clinical judgment (that is, their estimated pretest probability). The We can use the LR to find out how much the result of a diagnostic test will alter the pretest probability of a given diagnosis. An LR of 1 means that there will be no change: performing the test will not give any new information nor alter your clinical judgment as to whether the patient has the disease or not. A test with an LR of greater than 1 increases the probability that the patient has the disease over clinical judgment alone and an LR of less than 1 decreases this probability. There is no hard and fast rule about what size LR is clinically useful. However, as a rough guide, LRs of greater than 10 or less than 0-1 can change a pre-test probability significantly. LRs between 1 and 2, or 0 5 and 1, alter the probability to only a very small extent and are unlikely to be important in clinical practice. Intermediate figures can generate small, but possibly important, changes in probability.
Once we know the LR of a test, and whether it is likely to have clinical significance, we need to combine it with the pre-test probability to decide whether the test will alter our clinical management. Combining likelihoods requires cumbersome calculation.3 Fortunately, Fagan22 has devised a simple nomogram (fig) which does all the work. This allows us to combine pre-test probability with the LR of a test to give a post-test probability (that is, the probability of a diagnosis once information from the test result has been incorporated). The first column of the nomogram shows the pre-test probability, the second column gives the LR and the third gives post-test probability. To find out if a given test would alter your clinical judgment, anchor a ruler on the pre-test probability. Then rotate it to pass through the LR for the test in question and read off the post-test probability in the third column.
In the example under appraisal, the LR of LCR is so large that for any pre-test probability, however large or small, the likelihood of infec-tion in the presence of a positive test is extremely high. For example, an asymptomatic patient attending a pre-termination clinic, who has a pre-test probability of infection of 15 
